吉瑪基因是由海歸學者團隊共同創辦的高科技生物技術公司，目前約有員工300人，場地面積13,000m2。公司長期專注于RNA領域，擁有一體化的RNA技術整合開發平臺，可以完成從RNA單體生產、oligo設計和合成、針對靶基因的高通量篩選、體內/體外評價等臨床前研究。核酸原料藥GMP生產車間和生產基地也能為未來的臨床研究、藥品注冊和商業化生產提供支持。
公司的伴隨診斷包括熒光定量、質譜、RNAFISH三個技術平臺，同時建成了1,000m2的三類診斷試劑GMP生產車間。
動物平臺有轉基因動物、CDX、PDX動物模型，還有配備有1,340m2的SPF級的動物房。
吉瑪公司希望利用現有平臺為大型藥企盡快進入RNA藥物領域提供平臺和支持。
Genepharma is a high-tech biotechnology company founded by overseas scholars. At present, it has about 300 employees and a site area of 13,000m2.
The company has long been dedicated to the RNA field, boasting an integrated RNA technology development platform capable of handling preclinical studies from single RNA production, oligonucleotide design and synthesis, high-throughput screening for target genes, to in vivo/in vitro evaluation. The GMP manufacturing facilities and production bases for nucleic acid APIs also support future clinical research, drug registration, and commercial production.
The companys companion diagnostics include three technology platforms: fluorescence quantitative, mass spectrometry and RNA FISH. At the same time, a GMP production workshop of 1,000m2 for class III diagnostic reagents has been built.
The animal platform has transgenic animals, CDX and PDX animal models, as well as an SPF level 1,340m2 animal house.
Genepharma hopes to use the existing platform to provide a platform and support for large pharmaceutical companies to enter the RNA drug field as soon as possible.